OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Yannick Bulliard, Börje S. Andersson, Mehmet A. Baysal, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 24
Yannick Bulliard, Börje S. Andersson, Mehmet A. Baysal, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 24
Showing 24 citing articles:
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
Tingting Yue, Yue Sun, Yun Dai, et al.
Blood Reviews (2025), pp. 101256-101256
Closed Access
Tingting Yue, Yue Sun, Yun Dai, et al.
Blood Reviews (2025), pp. 101256-101256
Closed Access
Blockade of TSP-1/CD47 signal axis promotes donor hematopoietic engraftment by improving SEC/MK niche function
Feng Wang, Yanhou Liu, Ting Zhang, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 111952-111952
Open Access
Feng Wang, Yanhou Liu, Ting Zhang, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 111952-111952
Open Access
Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells
Jiang Guoyun, Qin Yuefeng, Huang Zhenglan, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Jiang Guoyun, Qin Yuefeng, Huang Zhenglan, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study
Danyang Li, Rui Liu, Zhonghua Fu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Danyang Li, Rui Liu, Zhonghua Fu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Development of Ingenui-T, a Novel Vein-to-Vein Solution for Rapid Autologous CAR T-Cell Manufacturing Starting From Whole Blood, for the Treatment of Autoimmune Diseases
Daniel Anaya, Brandon Kwong, Soo Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Daniel Anaya, Brandon Kwong, Soo Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Enhancing the Efficacy of CAR-T Cell Therapy: A Comprehensive Exploration of Cellular Strategies and Molecular Dynamics
Mehmet A. Baysal, Abhijit Chakraborty, Apostolia M. Tsimberidou
Journal of Cancer Immunology (2024) Vol. 6, Iss. 1, pp. 20-28
Open Access | Times Cited: 2
Mehmet A. Baysal, Abhijit Chakraborty, Apostolia M. Tsimberidou
Journal of Cancer Immunology (2024) Vol. 6, Iss. 1, pp. 20-28
Open Access | Times Cited: 2
Overcoming the challenges encountered in CAR-T therapy: latest updates from the 2023 ASH annual conference
Ting-Ting Zhang, Yicheng Zhang, Jia Wei
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Ting-Ting Zhang, Yicheng Zhang, Jia Wei
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Prospects and challenges of CAR-T in the treatment of ovarian cancer
Biqing Chen, Jiaqi Liu
International Immunopharmacology (2024) Vol. 133, pp. 112112-112112
Closed Access | Times Cited: 2
Biqing Chen, Jiaqi Liu
International Immunopharmacology (2024) Vol. 133, pp. 112112-112112
Closed Access | Times Cited: 2
Accelerating CAR T cell manufacturing with an automated next-day process
Mina Ahmadi, Nicholas Putnam, Max Dotson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Mina Ahmadi, Nicholas Putnam, Max Dotson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Tuning CAR T-cell therapies for efficacy and reduced toxicity
Danielle Blud, Patricia Rubio-Reyes, Rachel Perret, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 333-344
Closed Access | Times Cited: 1
Danielle Blud, Patricia Rubio-Reyes, Rachel Perret, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 333-344
Closed Access | Times Cited: 1
Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach
O. Bar, Angel Porgador, Tomer Cooks
Journal of Extracellular Biology (2024) Vol. 3, Iss. 9
Open Access | Times Cited: 1
O. Bar, Angel Porgador, Tomer Cooks
Journal of Extracellular Biology (2024) Vol. 3, Iss. 9
Open Access | Times Cited: 1
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
L Chen, Wenjing Qian, Fangfang Pan, et al.
Immunotherapy (2023) Vol. 16, Iss. 3, pp. 143-159
Open Access | Times Cited: 4
L Chen, Wenjing Qian, Fangfang Pan, et al.
Immunotherapy (2023) Vol. 16, Iss. 3, pp. 143-159
Open Access | Times Cited: 4
DNT cells mediate resistance to CAR-T cells therapy in a pediatric patient with relapsed and refractory B-ALL
Ruotong Chen, Qianshan Tao, Fan Wu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 7, pp. 2551-2556
Closed Access
Ruotong Chen, Qianshan Tao, Fan Wu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 7, pp. 2551-2556
Closed Access
BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1
Songnan Sui, Mengjun Zhong, Shuxin Zhong, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Songnan Sui, Mengjun Zhong, Shuxin Zhong, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias
Mercedes Guerrero-Murillo, Aina Rill-Hinarejos, Juan L. Trincado, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101803-101803
Open Access
Mercedes Guerrero-Murillo, Aina Rill-Hinarejos, Juan L. Trincado, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101803-101803
Open Access
Nanoradiosentizers with X Ray-Actuatable Supramolecular Aptamer Building Units for Programmable Immunostimulatory T Cell Engagement
Jinming He, Xijiao Ren, Qiqi Zhang, et al.
Biomaterials (2024) Vol. 315, pp. 122924-122924
Closed Access
Jinming He, Xijiao Ren, Qiqi Zhang, et al.
Biomaterials (2024) Vol. 315, pp. 122924-122924
Closed Access
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
Haotian Ma, Zhifeng Yan, Runxia Gu, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access
Haotian Ma, Zhifeng Yan, Runxia Gu, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access
Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming
Yueyu Dai, Yue Liu, Lingna An, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009949-e009949
Open Access
Yueyu Dai, Yue Liu, Lingna An, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009949-e009949
Open Access
Short-chain fatty acids are a key mediator of gut microbial regulation of T cell trafficking and differentiation after traumatic brain injury
Marta Celorrio, Kirill Shumilov, Allen Ni, et al.
Research Square (Research Square) (2024)
Open Access
Marta Celorrio, Kirill Shumilov, Allen Ni, et al.
Research Square (Research Square) (2024)
Open Access
Accelerating CAR T cell manufacturing with an automated next-day process
Mojtaba Ahmadi, Nicholas Putnam, Max Dotson, et al.
Current Research in Translational Medicine (2024) Vol. 73, Iss. 1, pp. 103489-103489
Open Access
Mojtaba Ahmadi, Nicholas Putnam, Max Dotson, et al.
Current Research in Translational Medicine (2024) Vol. 73, Iss. 1, pp. 103489-103489
Open Access
Recent Advancement in Car-T-Cell Therapy
Vivek Pazhamalai, G. Manideepa, R. Mathumida
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 237-264
Closed Access
Vivek Pazhamalai, G. Manideepa, R. Mathumida
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 237-264
Closed Access
Engineering a controllable and reversible switch for CAR-based cellular immunotherapies via a genetic code expansion system
Yue Liu, Lingna An, Xiaoqi Wang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access
Yue Liu, Lingna An, Xiaoqi Wang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access
Optimizing CAR-T Cell Function in Solid Tumor Microenvironment: Insights from Culture Media Additives
Wenwen Chen, Lei Xu, Zhigang Guo, et al.
Current Research in Translational Medicine (2024) Vol. 73, Iss. 2, pp. 103491-103491
Closed Access
Wenwen Chen, Lei Xu, Zhigang Guo, et al.
Current Research in Translational Medicine (2024) Vol. 73, Iss. 2, pp. 103491-103491
Closed Access
